Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT06148935
Eligibility Criteria:
Inclusion Criteria:
* Adult aged 19 years or older
* Chronic HF (NYHA functional class II, III, or IV) Reduced left ventricular ejection fraction (\< 45%) within 12 months before enrollment
* Worsening of heart failure (hospitalized within 6 months before enrollment or intravenous diuretic therapy without hospitalization within 3 months)
* Participants who have been prescribed Verquvo (Vericiguat) as per locally approved label and didn't receive Verquvo (Vericiguat) therapy previously.
* Written informed consent from subject or legal representative; assent from subject when appropriate
Exclusion Criteria:
* Contraindication according to the local authorized label (including known hypersensitivity to the drug substance or any of its components, pregnancy)
* Participants participating in an investigational program with interventions outside of routine clinical practice
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT06148935
Study Brief:
Protocol Section:
NCT06148935